BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28884421)

  • 1. Assessing responsiveness over time of the PROMIS
    Reeve BB; Edwards LJ; Jaeger BC; Hinds PS; Dampier C; Gipson DS; Selewski DT; Troost JP; Thissen D; Barry V; Gross HE; DeWalt DA
    Qual Life Res; 2018 Jan; 27(1):249-257. PubMed ID: 28884421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium study.
    Selewski DT; Troost JP; Cummings D; Massengill SF; Gbadegesin RA; Greenbaum LA; Shatat IF; Cai Y; Kapur G; Hebert D; Somers MJ; Trachtman H; Pais P; Seifert ME; Goebel J; Sethna CB; Mahan JD; Gross HE; Herreshoff E; Liu Y; Carlozzi NE; Reeve BB; DeWalt DA; Gipson DS
    Health Qual Life Outcomes; 2017 Aug; 15(1):166. PubMed ID: 28835233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaining the PROMIS perspective from children with nephrotic syndrome: a Midwest pediatric nephrology consortium study.
    Gipson DS; Selewski DT; Massengill SF; Wickman L; Messer KL; Herreshoff E; Bowers C; Ferris ME; Mahan JD; Greenbaum LA; MacHardy J; Kapur G; Chand DH; Goebel J; Barletta GM; Geary D; Kershaw DB; Pan CG; Gbadegesin R; Hidalgo G; Lane JC; Leiser JD; Plattner BW; Song PX; Thissen D; Liu Y; Gross HE; DeWalt DA
    Health Qual Life Outcomes; 2013 Mar; 11():30. PubMed ID: 23510630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PROMIS(®) pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions.
    DeWalt DA; Gross HE; Gipson DS; Selewski DT; DeWitt EM; Dampier CD; Hinds PS; Huang IC; Thissen D; Varni JW
    Qual Life Res; 2015 Sep; 24(9):2195-208. PubMed ID: 25715946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial Evaluation of the Pediatric PROMIS® Health Domains in Children and Adolescents With Sickle Cell Disease.
    Dampier C; Barry V; Gross HE; Lui Y; Thornburg CD; DeWalt DA; Reeve BB
    Pediatr Blood Cancer; 2016 Jun; 63(6):1031-7. PubMed ID: 26895143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness of PROMIS® Pediatric Measures to Hospitalizations for Sickle Pain and Subsequent Recovery.
    Dampier C; Jaeger B; Gross HE; Barry V; Edwards L; Lui Y; DeWalt DA; Reeve BB
    Pediatr Blood Cancer; 2016 Jun; 63(6):1038-45. PubMed ID: 26853841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding construct validity of established and new PROMIS Pediatric measures for children and adolescents receiving cancer treatment.
    Reeve BB; McFatrich M; Mack JW; Pinheiro LC; Jacobs SS; Baker JN; Withycombe JS; Lin L; Mann CM; Villabroza KR; Hinds PS
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28160. PubMed ID: 31904157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agreement Between Child Self-report and Caregiver-Proxy Report for Symptoms and Functioning of Children Undergoing Cancer Treatment.
    Mack JW; McFatrich M; Withycombe JS; Maurer SH; Jacobs SS; Lin L; Lucas NR; Baker JN; Mann CM; Sung L; Tomlinson D; Hinds PS; Reeve BB
    JAMA Pediatr; 2020 Nov; 174(11):e202861. PubMed ID: 32832975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising insights into the health related quality of life for children with severe obesity.
    Selewski DT; Collier DN; MacHardy J; Gross HE; Pickens EM; Cooper AW; Bullock S; Earls MF; Pratt KJ; Scanlon K; McNeill JD; Messer KL; Lu Y; Thissen D; DeWalt DA; Gipson DS
    Health Qual Life Outcomes; 2013 Mar; 11():29. PubMed ID: 23452863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate Weightbearing Restrictions Are Associated with Worse Depressive Symptoms and Anxiety in Children Aged 5 to 7 Years with Perthes Disease.
    Do DH; Valencia AA; Jo CH; Kim HKW
    Clin Orthop Relat Res; 2022 Mar; 480(3):587-599. PubMed ID: 34652293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weightbearing and Activity Restriction Treatments and Quality of Life in Patients with Perthes Disease.
    Do DH; McGuire MF; Jo CH; Kim HKW
    Clin Orthop Relat Res; 2021 Jun; 479(6):1360-1370. PubMed ID: 33394755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROMIS pediatric measures validated in a longitudinal study design in pediatric oncology.
    Hinds PS; Wang J; Cheng YI; Stern E; Waldron M; Gross H; DeWalt DA; Jacobs SS
    Pediatr Blood Cancer; 2019 May; 66(5):e27606. PubMed ID: 30663254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaining the Patient Reported Outcomes Measurement Information System (PROMIS) perspective in chronic kidney disease: a Midwest Pediatric Nephrology Consortium study.
    Selewski DT; Massengill SF; Troost JP; Wickman L; Messer KL; Herreshoff E; Bowers C; Ferris ME; Mahan JD; Greenbaum LA; MacHardy J; Kapur G; Chand DH; Goebel J; Barletta GM; Geary D; Kershaw DB; Pan CG; Gbadegesin R; Hidalgo G; Lane JC; Leiser JD; Song PX; Thissen D; Liu Y; Gross HE; DeWalt DA; Gipson DS
    Pediatr Nephrol; 2014 Dec; 29(12):2347-56. PubMed ID: 24908324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the new pediatric PROMIS measures of pain and physical experiences for children with sickle cell disease.
    Singh A; DasGupta M; Simpson PM; Panepinto JA
    Pediatr Blood Cancer; 2019 May; 66(5):e27633. PubMed ID: 30688017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity and Responsiveness of the Patient-reported Outcomes Measurement Information System in Children With Ulcerative Colitis.
    Brenner EJ; Long MD; Mann CM; Lin L; Chen W; Reyes C; Bahnson KM; Reeve BB; Kappelman MD
    J Pediatr Gastroenterol Nutr; 2021 Jul; 73(1):67-72. PubMed ID: 33633083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary investigation of the psychometric properties of PROMIS® scales in emerging adults with sickle cell disease.
    Hildenbrand AK; Quinn CT; Mara CA; Peugh JL; McTate EA; Britto MT; Crosby LE
    Health Psychol; 2019 May; 38(5):386-390. PubMed ID: 31045421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠.
    Keller S; Yang M; Treadwell MJ; Hassell KL
    Health Qual Life Outcomes; 2017 Jun; 15(1):117. PubMed ID: 28577358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of the Patient-reported Outcomes Measurement Information System (PROMIS) Pediatric Measures to Changes in Disease Status and Quality of Life Among Children and Adolescents With Crohn's Disease.
    Brenner EJ; Long MD; Mann CM; Chen W; Reyes C; Lin L; Reeve BB; Kappelman MD
    Inflamm Bowel Dis; 2021 Feb; 27(3):344-351. PubMed ID: 32435792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study.
    Selewski DT; Troost JP; Massengill SF; Gbadegesin RA; Greenbaum LA; Shatat IF; Cai Y; Kapur G; Hebert D; Somers MJ; Trachtman H; Pais P; Seifert ME; Goebel J; Sethna CB; Mahan JD; Gross HE; Herreshoff E; Liu Y; Song PX; Reeve BB; DeWalt DA; Gipson DS
    Pediatr Nephrol; 2015 Sep; 30(9):1467-76. PubMed ID: 25784017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness to Change in PROMIS(®) Measures among Children with Asthma: A Report from the PROMIS(®) Pediatric Asthma Study.
    Howell CR; Thompson LA; Gross HE; Reeve BB; DeWalt DA; Huang IC
    Value Health; 2016; 19(2):192-201. PubMed ID: 27021753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.